JP2021502102A5 - - Google Patents

Download PDF

Info

Publication number
JP2021502102A5
JP2021502102A5 JP2020526075A JP2020526075A JP2021502102A5 JP 2021502102 A5 JP2021502102 A5 JP 2021502102A5 JP 2020526075 A JP2020526075 A JP 2020526075A JP 2020526075 A JP2020526075 A JP 2020526075A JP 2021502102 A5 JP2021502102 A5 JP 2021502102A5
Authority
JP
Japan
Prior art keywords
nucleic acid
cell
cells
pharmaceutical composition
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020526075A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021502102A (ja
Filing date
Publication date
Priority claimed from GBGB1718697.4A external-priority patent/GB201718697D0/en
Application filed filed Critical
Publication of JP2021502102A publication Critical patent/JP2021502102A/ja
Publication of JP2021502102A5 publication Critical patent/JP2021502102A5/ja
Withdrawn legal-status Critical Current

Links

JP2020526075A 2017-11-13 2018-11-12 細胞 Withdrawn JP2021502102A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1718697.4A GB201718697D0 (en) 2017-11-13 2017-11-13 Cell
GB1718697.4 2017-11-13
PCT/GB2018/053262 WO2019092442A1 (en) 2017-11-13 2018-11-12 Cell

Publications (2)

Publication Number Publication Date
JP2021502102A JP2021502102A (ja) 2021-01-28
JP2021502102A5 true JP2021502102A5 (cg-RX-API-DMAC7.html) 2021-10-28

Family

ID=60788303

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020526075A Withdrawn JP2021502102A (ja) 2017-11-13 2018-11-12 細胞

Country Status (8)

Country Link
US (1) US20200345776A1 (cg-RX-API-DMAC7.html)
EP (1) EP3710045A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021502102A (cg-RX-API-DMAC7.html)
CN (1) CN111344006A (cg-RX-API-DMAC7.html)
AU (1) AU2018364490A1 (cg-RX-API-DMAC7.html)
CA (1) CA3082265A1 (cg-RX-API-DMAC7.html)
GB (1) GB201718697D0 (cg-RX-API-DMAC7.html)
WO (1) WO2019092442A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019025800A1 (en) * 2017-08-02 2019-02-07 Autolus Limited CELLS EXPRESSING A CHIMERIC ANTIGENIC RECEPTOR OR A MANIPULATED TCR AND COMPRISING A SELECTIVELY EXPRESSED SELECTIVE NUCLEOTIDE SEQUENCE
EP3934666A1 (en) 2019-03-08 2022-01-12 Autolus Limited Compositions and methods comprising engineered chimeric antigen receptor and modulator of car
CN117043180A (zh) * 2020-09-11 2023-11-10 新加坡国立大学 用于器官移植患者的免疫疗法的免疫抑制剂药物抗性装甲tcr t细胞
CN116463362B (zh) * 2023-06-15 2023-09-19 中国中医科学院中药研究所 一种细胞分裂抑制剂的制备方法
CN117384931B (zh) * 2023-12-06 2024-03-08 中国中医科学院中药研究所 一种GSK-3β抑制剂的制备方法

Similar Documents

Publication Publication Date Title
JP7745032B2 (ja) 一本鎖および多鎖キメラポリペプチドならびにその使用方法
JP2020511115A5 (cg-RX-API-DMAC7.html)
JP6775515B2 (ja) トランスポザーゼポリペプチド及びその使用
JP2022519595A5 (cg-RX-API-DMAC7.html)
JP2020530280A5 (cg-RX-API-DMAC7.html)
KR20190133732A (ko) 자연 살해 세포의 ex vivo 확장 및 활성화를 위한 자극성 세포주
JP2009525727A (ja) 操作された抗体−ストレスタンパク質融合体
KR20010072112A (ko) 암 억제 유전자 더블유티1의 생산물에 기초한 암항원
JP2013505713A5 (cg-RX-API-DMAC7.html)
CN109312361A (zh) 转座子系统及应用方法
JP2021525534A5 (cg-RX-API-DMAC7.html)
JP2020530993A5 (cg-RX-API-DMAC7.html)
UA79235C2 (en) Il-18 mutant polypeptide, extracted dna coded il-18 mutant polypeptide, vector and pharmaceutical composition
Darnell RNA regulation in neurologic disease and cancer
JP2024514355A5 (cg-RX-API-DMAC7.html)
JP2022521278A (ja) 人工免疫監視キメラ抗原受容体(ai-car)及びそれを発現する細胞
CN117069844B (zh) 包含特定等电点的抗人bcma纳米抗体的双特异性抗体及应用
CN107475275A (zh) 嵌合抗原受体及其表达基因、双抗原调节的嵌合抗原受体修饰的t细胞及其应用
WO2007010989A1 (ja) 神経分化誘導ペプチド及びその利用
EP1809660B1 (en) A thymus-specific protein
CN116419928A (zh) Fcα受体结合抗体
JP6684211B2 (ja) B細胞集団の製造方法
CN117186230B (zh) 包含亲水性氨基酸的抗人bcma纳米抗体的双特异性抗体及应用
CN119638850A (zh) 双特异性细胞因子融合蛋白及其应用
US20190338001A1 (en) Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same